nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—bone cancer—germ cell cancer	0.194	0.369	CtDrD
Methotrexate—muscle cancer—germ cell cancer	0.171	0.326	CtDrD
Methotrexate—testicular cancer—germ cell cancer	0.161	0.306	CtDrD
Methotrexate—ABCC10—Etoposide—germ cell cancer	0.0446	0.164	CbGbCtD
Methotrexate—ABCC1—Dactinomycin—germ cell cancer	0.0305	0.112	CbGbCtD
Methotrexate—ABCC3—Cisplatin—germ cell cancer	0.0285	0.105	CbGbCtD
Methotrexate—ABCC3—Etoposide—germ cell cancer	0.028	0.103	CbGbCtD
Methotrexate—ABCG2—Dactinomycin—germ cell cancer	0.0204	0.0751	CbGbCtD
Methotrexate—ABCC1—Vinblastine—germ cell cancer	0.0191	0.0703	CbGbCtD
Methotrexate—ABCC1—Etoposide—germ cell cancer	0.0172	0.0633	CbGbCtD
Methotrexate—ABCC2—Vinblastine—germ cell cancer	0.0141	0.052	CbGbCtD
Methotrexate—ABCC2—Cisplatin—germ cell cancer	0.013	0.0477	CbGbCtD
Methotrexate—ABCC2—Etoposide—germ cell cancer	0.0127	0.0469	CbGbCtD
Methotrexate—ABCG2—Cisplatin—germ cell cancer	0.0117	0.0431	CbGbCtD
Methotrexate—ABCG2—Etoposide—germ cell cancer	0.0115	0.0424	CbGbCtD
Methotrexate—ABCB1—Dactinomycin—germ cell cancer	0.00736	0.0271	CbGbCtD
Methotrexate—ABCB1—Vinblastine—germ cell cancer	0.00461	0.017	CbGbCtD
Methotrexate—ABCB1—Cisplatin—germ cell cancer	0.00423	0.0156	CbGbCtD
Methotrexate—ABCB1—Etoposide—germ cell cancer	0.00416	0.0153	CbGbCtD
Methotrexate—TYMS—Vinorelbine—Vinblastine—germ cell cancer	0.000459	0.35	CbGdCrCtD
Methotrexate—TYMS—Podofilox—Etoposide—germ cell cancer	0.000458	0.35	CbGdCrCtD
Methotrexate—TYMS—Vincristine—Vinblastine—germ cell cancer	0.000392	0.3	CbGdCrCtD
Methotrexate—DHFR—eye—germ cell cancer	0.000223	0.00352	CbGeAlD
Methotrexate—SLCO4C1—bone marrow—germ cell cancer	0.000222	0.0035	CbGeAlD
Methotrexate—GGH—head—germ cell cancer	0.000222	0.0035	CbGeAlD
Methotrexate—DHFR—retina—germ cell cancer	0.000221	0.00348	CbGeAlD
Methotrexate—ATIC—adrenal gland—germ cell cancer	0.00022	0.00347	CbGeAlD
Methotrexate—FPGS—spinal cord—germ cell cancer	0.000219	0.00346	CbGeAlD
Methotrexate—AOX1—trigeminal ganglion—germ cell cancer	0.000219	0.00346	CbGeAlD
Methotrexate—SLC46A1—testis—germ cell cancer	0.000218	0.00343	CbGeAlD
Methotrexate—ATIC—midbrain—germ cell cancer	0.000217	0.00343	CbGeAlD
Methotrexate—PGD—eye—germ cell cancer	0.000214	0.00338	CbGeAlD
Methotrexate—GGH—testis—germ cell cancer	0.000214	0.00338	CbGeAlD
Methotrexate—ABCC10—trigeminal ganglion—germ cell cancer	0.000213	0.00336	CbGeAlD
Methotrexate—PGD—retina—germ cell cancer	0.000212	0.00335	CbGeAlD
Methotrexate—FPGS—female gonad—germ cell cancer	0.000212	0.00335	CbGeAlD
Methotrexate—ATIC—spinal cord—germ cell cancer	0.000212	0.00334	CbGeAlD
Methotrexate—SLC19A1—brain—germ cell cancer	0.000212	0.00334	CbGeAlD
Methotrexate—ATIC—female gonad—germ cell cancer	0.000205	0.00324	CbGeAlD
Methotrexate—TYMS—telencephalon—germ cell cancer	0.000205	0.00324	CbGeAlD
Methotrexate—SLCO1C1—pituitary gland—germ cell cancer	0.000205	0.00323	CbGeAlD
Methotrexate—SLC19A1—lymph node—germ cell cancer	0.000205	0.00323	CbGeAlD
Methotrexate—DHFR—telencephalon—germ cell cancer	0.000203	0.00321	CbGeAlD
Methotrexate—SLC46A1—cerebellum—germ cell cancer	0.000201	0.00317	CbGeAlD
Methotrexate—SLC16A1—eye—germ cell cancer	0.0002	0.00316	CbGeAlD
Methotrexate—SLC16A1—retina—germ cell cancer	0.000198	0.00313	CbGeAlD
Methotrexate—GGH—cerebellum—germ cell cancer	0.000198	0.00312	CbGeAlD
Methotrexate—FPGS—endocrine gland—germ cell cancer	0.000197	0.00311	CbGeAlD
Methotrexate—TYMS—skin of body—germ cell cancer	0.000196	0.00309	CbGeAlD
Methotrexate—PGD—telencephalon—germ cell cancer	0.000195	0.00308	CbGeAlD
Methotrexate—FPGS—head—germ cell cancer	0.000195	0.00307	CbGeAlD
Methotrexate—SLCO1B3—endocrine gland—germ cell cancer	0.000193	0.00305	CbGeAlD
Methotrexate—DHFR—decidua—germ cell cancer	0.000193	0.00304	CbGeAlD
Methotrexate—ATIC—endocrine gland—germ cell cancer	0.000191	0.00301	CbGeAlD
Methotrexate—AOX1—eye—germ cell cancer	0.000189	0.00298	CbGeAlD
Methotrexate—ATIC—head—germ cell cancer	0.000188	0.00297	CbGeAlD
Methotrexate—FPGS—testis—germ cell cancer	0.000188	0.00297	CbGeAlD
Methotrexate—PGD—skin of body—germ cell cancer	0.000186	0.00294	CbGeAlD
Methotrexate—PGD—decidua—germ cell cancer	0.000185	0.00292	CbGeAlD
Methotrexate—SLCO3A1—gonad—germ cell cancer	0.000185	0.00291	CbGeAlD
Methotrexate—SLC16A1—telencephalon—germ cell cancer	0.000182	0.00288	CbGeAlD
Methotrexate—ATIC—testis—germ cell cancer	0.000182	0.00287	CbGeAlD
Methotrexate—SLCO1C1—midbrain—germ cell cancer	0.000181	0.00285	CbGeAlD
Methotrexate—SLCO3A1—pituitary gland—germ cell cancer	0.00018	0.00284	CbGeAlD
Methotrexate—SLCO1C1—spinal cord—germ cell cancer	0.000176	0.00278	CbGeAlD
Methotrexate—SLC22A8—trigeminal ganglion—germ cell cancer	0.000176	0.00277	CbGeAlD
Methotrexate—SLCO3A1—medulla oblongata—germ cell cancer	0.000174	0.00274	CbGeAlD
Methotrexate—FPGS—cerebellum—germ cell cancer	0.000174	0.00274	CbGeAlD
Methotrexate—SLC16A1—decidua—germ cell cancer	0.000173	0.00273	CbGeAlD
Methotrexate—TYMS—gonad—germ cell cancer	0.000171	0.0027	CbGeAlD
Methotrexate—DHFR—gonad—germ cell cancer	0.00017	0.00268	CbGeAlD
Methotrexate—DHFR—uterus—germ cell cancer	0.000168	0.00266	CbGeAlD
Methotrexate—ATIC—cerebellum—germ cell cancer	0.000168	0.00265	CbGeAlD
Methotrexate—ABCC10—telencephalon—germ cell cancer	0.000167	0.00264	CbGeAlD
Methotrexate—DHFR—pituitary gland—germ cell cancer	0.000165	0.00261	CbGeAlD
Methotrexate—MTHFR—adrenal gland—germ cell cancer	0.000164	0.00258	CbGeAlD
Methotrexate—SLC46A1—brain—germ cell cancer	0.000163	0.00258	CbGeAlD
Methotrexate—AOX1—decidua—germ cell cancer	0.000163	0.00257	CbGeAlD
Methotrexate—PGD—gonad—germ cell cancer	0.000163	0.00257	CbGeAlD
Methotrexate—PGD—uterus—germ cell cancer	0.000162	0.00255	CbGeAlD
Methotrexate—SLCO3A1—adrenal gland—germ cell cancer	0.000161	0.00254	CbGeAlD
Methotrexate—GGH—brain—germ cell cancer	0.000161	0.00253	CbGeAlD
Methotrexate—DHFR—medulla oblongata—germ cell cancer	0.00016	0.00252	CbGeAlD
Methotrexate—ABCC3—decidua—germ cell cancer	0.00016	0.00252	CbGeAlD
Methotrexate—PGD—pituitary gland—germ cell cancer	0.000159	0.00251	CbGeAlD
Methotrexate—SLCO3A1—midbrain—germ cell cancer	0.000159	0.00251	CbGeAlD
Methotrexate—ABCC10—decidua—germ cell cancer	0.000159	0.0025	CbGeAlD
Methotrexate—SLCO1C1—endocrine gland—germ cell cancer	0.000159	0.0025	CbGeAlD
Methotrexate—SLC46A1—lymph node—germ cell cancer	0.000158	0.00249	CbGeAlD
Methotrexate—SLCO1C1—head—germ cell cancer	0.000157	0.00247	CbGeAlD
Methotrexate—GGH—lymph node—germ cell cancer	0.000155	0.00245	CbGeAlD
Methotrexate—SLCO3A1—spinal cord—germ cell cancer	0.000155	0.00245	CbGeAlD
Methotrexate—SLC22A11—endocrine gland—germ cell cancer	0.000154	0.00243	CbGeAlD
Methotrexate—PGD—medulla oblongata—germ cell cancer	0.000153	0.00242	CbGeAlD
Methotrexate—MTHFR—female gonad—germ cell cancer	0.000153	0.00241	CbGeAlD
Methotrexate—SLC16A1—gonad—germ cell cancer	0.000152	0.0024	CbGeAlD
Methotrexate—SLCO1C1—testis—germ cell cancer	0.000151	0.00239	CbGeAlD
Methotrexate—SLC22A8—eye—germ cell cancer	0.000151	0.00239	CbGeAlD
Methotrexate—SLC16A1—uterus—germ cell cancer	0.000151	0.00239	CbGeAlD
Methotrexate—SLC22A7—endocrine gland—germ cell cancer	0.00015	0.00237	CbGeAlD
Methotrexate—SLCO3A1—female gonad—germ cell cancer	0.00015	0.00237	CbGeAlD
Methotrexate—TYMS—adrenal gland—germ cell cancer	0.000149	0.00235	CbGeAlD
Methotrexate—SLC16A1—pituitary gland—germ cell cancer	0.000148	0.00234	CbGeAlD
Methotrexate—DHFR—adrenal gland—germ cell cancer	0.000148	0.00233	CbGeAlD
Methotrexate—TYMS—midbrain—germ cell cancer	0.000147	0.00232	CbGeAlD
Methotrexate—DHFR—midbrain—germ cell cancer	0.000146	0.0023	CbGeAlD
Methotrexate—TYMS—bone marrow—germ cell cancer	0.000144	0.00228	CbGeAlD
Methotrexate—SLCO1A2—telencephalon—germ cell cancer	0.000144	0.00228	CbGeAlD
Methotrexate—AOX1—gonad—germ cell cancer	0.000144	0.00227	CbGeAlD
Methotrexate—SLC22A7—testis—germ cell cancer	0.000143	0.00226	CbGeAlD
Methotrexate—SLC16A1—medulla oblongata—germ cell cancer	0.000143	0.00226	CbGeAlD
Methotrexate—DHFR—bone marrow—germ cell cancer	0.000143	0.00226	CbGeAlD
Methotrexate—AOX1—uterus—germ cell cancer	0.000143	0.00225	CbGeAlD
Methotrexate—DHFR—spinal cord—germ cell cancer	0.000142	0.00225	CbGeAlD
Methotrexate—PGD—adrenal gland—germ cell cancer	0.000142	0.00224	CbGeAlD
Methotrexate—MTHFR—endocrine gland—germ cell cancer	0.000142	0.00224	CbGeAlD
Methotrexate—FPGS—brain—germ cell cancer	0.000141	0.00223	CbGeAlD
Methotrexate—PGD—midbrain—germ cell cancer	0.00014	0.00221	CbGeAlD
Methotrexate—AOX1—pituitary gland—germ cell cancer	0.00014	0.00221	CbGeAlD
Methotrexate—MTHFR—head—germ cell cancer	0.00014	0.00221	CbGeAlD
Methotrexate—ABCC10—gonad—germ cell cancer	0.00014	0.00221	CbGeAlD
Methotrexate—SLCO3A1—endocrine gland—germ cell cancer	0.00014	0.0022	CbGeAlD
Methotrexate—TYMS—female gonad—germ cell cancer	0.000139	0.0022	CbGeAlD
Methotrexate—ABCC10—uterus—germ cell cancer	0.000139	0.00219	CbGeAlD
Methotrexate—DHFR—female gonad—germ cell cancer	0.000138	0.00217	CbGeAlD
Methotrexate—SLCO3A1—head—germ cell cancer	0.000138	0.00217	CbGeAlD
Methotrexate—PGD—bone marrow—germ cell cancer	0.000137	0.00217	CbGeAlD
Methotrexate—PGD—spinal cord—germ cell cancer	0.000137	0.00216	CbGeAlD
Methotrexate—ATIC—brain—germ cell cancer	0.000137	0.00215	CbGeAlD
Methotrexate—FPGS—lymph node—germ cell cancer	0.000136	0.00215	CbGeAlD
Methotrexate—ABCC10—pituitary gland—germ cell cancer	0.000136	0.00215	CbGeAlD
Methotrexate—MTHFR—testis—germ cell cancer	0.000135	0.00213	CbGeAlD
Methotrexate—SLCO3A1—testis—germ cell cancer	0.000133	0.0021	CbGeAlD
Methotrexate—SLC16A1—adrenal gland—germ cell cancer	0.000133	0.00209	CbGeAlD
Methotrexate—PGD—female gonad—germ cell cancer	0.000132	0.00209	CbGeAlD
Methotrexate—ATIC—lymph node—germ cell cancer	0.000132	0.00208	CbGeAlD
Methotrexate—ABCC10—medulla oblongata—germ cell cancer	0.000132	0.00208	CbGeAlD
Methotrexate—SLC16A1—midbrain—germ cell cancer	0.000131	0.00207	CbGeAlD
Methotrexate—TYMS—endocrine gland—germ cell cancer	0.000129	0.00204	CbGeAlD
Methotrexate—DHFR—endocrine gland—germ cell cancer	0.000128	0.00202	CbGeAlD
Methotrexate—TYMS—head—germ cell cancer	0.000128	0.00202	CbGeAlD
Methotrexate—SLC16A1—spinal cord—germ cell cancer	0.000128	0.00202	CbGeAlD
Methotrexate—DHFR—head—germ cell cancer	0.000127	0.002	CbGeAlD
Methotrexate—AOX1—adrenal gland—germ cell cancer	0.000125	0.00197	CbGeAlD
Methotrexate—MTHFR—cerebellum—germ cell cancer	0.000125	0.00197	CbGeAlD
Methotrexate—ABCG2—trigeminal ganglion—germ cell cancer	0.000125	0.00197	CbGeAlD
Methotrexate—SLC16A1—female gonad—germ cell cancer	0.000124	0.00195	CbGeAlD
Methotrexate—TYMS—testis—germ cell cancer	0.000123	0.00195	CbGeAlD
Methotrexate—PGD—endocrine gland—germ cell cancer	0.000123	0.00194	CbGeAlD
Methotrexate—SLCO3A1—cerebellum—germ cell cancer	0.000123	0.00194	CbGeAlD
Methotrexate—ABCC3—adrenal gland—germ cell cancer	0.000122	0.00193	CbGeAlD
Methotrexate—DHFR—testis—germ cell cancer	0.000122	0.00193	CbGeAlD
Methotrexate—ABCC10—adrenal gland—germ cell cancer	0.000122	0.00192	CbGeAlD
Methotrexate—PGD—head—germ cell cancer	0.000122	0.00192	CbGeAlD
Methotrexate—ABCC10—midbrain—germ cell cancer	0.00012	0.0019	CbGeAlD
Methotrexate—ABCC1—telencephalon—germ cell cancer	0.000118	0.00187	CbGeAlD
Methotrexate—Convulsion—Vinblastine—germ cell cancer	0.000118	0.00123	CcSEcCtD
Methotrexate—ABCC10—bone marrow—germ cell cancer	0.000118	0.00186	CbGeAlD
Methotrexate—PGD—testis—germ cell cancer	0.000117	0.00185	CbGeAlD
Methotrexate—ABCC10—spinal cord—germ cell cancer	0.000117	0.00185	CbGeAlD
Methotrexate—Agranulocytosis—Ifosfamide—germ cell cancer	0.000117	0.00123	CcSEcCtD
Methotrexate—AOX1—female gonad—germ cell cancer	0.000117	0.00184	CbGeAlD
Methotrexate—Alopecia—Bleomycin—germ cell cancer	0.000117	0.00122	CcSEcCtD
Methotrexate—Abdominal discomfort—Cisplatin—germ cell cancer	0.000117	0.00122	CcSEcCtD
Methotrexate—Erythema multiforme—Dactinomycin—germ cell cancer	0.000116	0.00122	CcSEcCtD
Methotrexate—Toxic epidermal necrolysis—Etoposide—germ cell cancer	0.000116	0.00121	CcSEcCtD
Methotrexate—Pancytopenia—Cisplatin—germ cell cancer	0.000115	0.00121	CcSEcCtD
Methotrexate—ABCC4—uterus—germ cell cancer	0.000115	0.00182	CbGeAlD
Methotrexate—SLC16A1—endocrine gland—germ cell cancer	0.000115	0.00181	CbGeAlD
Methotrexate—Erythema—Bleomycin—germ cell cancer	0.000115	0.0012	CcSEcCtD
Methotrexate—Discomfort—Vinblastine—germ cell cancer	0.000114	0.0012	CcSEcCtD
Methotrexate—ABCC3—female gonad—germ cell cancer	0.000114	0.0018	CbGeAlD
Methotrexate—TYMS—cerebellum—germ cell cancer	0.000114	0.0018	CbGeAlD
Methotrexate—ABCC10—female gonad—germ cell cancer	0.000114	0.00179	CbGeAlD
Methotrexate—SLC16A1—head—germ cell cancer	0.000114	0.00179	CbGeAlD
Methotrexate—SLCO1C1—brain—germ cell cancer	0.000114	0.00179	CbGeAlD
Methotrexate—Haemoglobin—Ifosfamide—germ cell cancer	0.000113	0.00118	CcSEcCtD
Methotrexate—SLCO1A2—medulla oblongata—germ cell cancer	0.000113	0.00179	CbGeAlD
Methotrexate—DHFR—cerebellum—germ cell cancer	0.000113	0.00178	CbGeAlD
Methotrexate—Hepatitis—Ifosfamide—germ cell cancer	0.000113	0.00118	CcSEcCtD
Methotrexate—Haemorrhage—Ifosfamide—germ cell cancer	0.000113	0.00118	CcSEcCtD
Methotrexate—ABCC1—decidua—germ cell cancer	0.000112	0.00177	CbGeAlD
Methotrexate—SLCO1B1—endocrine gland—germ cell cancer	0.000112	0.00177	CbGeAlD
Methotrexate—Urinary tract disorder—Ifosfamide—germ cell cancer	0.000111	0.00116	CcSEcCtD
Methotrexate—Urethral disorder—Ifosfamide—germ cell cancer	0.000111	0.00116	CcSEcCtD
Methotrexate—Chills—Dactinomycin—germ cell cancer	0.000111	0.00115	CcSEcCtD
Methotrexate—SLC16A1—testis—germ cell cancer	0.00011	0.00173	CbGeAlD
Methotrexate—SLCO1C1—lymph node—germ cell cancer	0.00011	0.00173	CbGeAlD
Methotrexate—Alopecia—Dactinomycin—germ cell cancer	0.000109	0.00114	CcSEcCtD
Methotrexate—Thrombocytopenia—Vinblastine—germ cell cancer	0.000109	0.00114	CcSEcCtD
Methotrexate—Visual impairment—Ifosfamide—germ cell cancer	0.000109	0.00114	CcSEcCtD
Methotrexate—AOX1—endocrine gland—germ cell cancer	0.000109	0.00171	CbGeAlD
Methotrexate—PGD—cerebellum—germ cell cancer	0.000109	0.00171	CbGeAlD
Methotrexate—SLC22A7—brain—germ cell cancer	0.000108	0.0017	CbGeAlD
Methotrexate—Erythema—Dactinomycin—germ cell cancer	0.000107	0.00112	CcSEcCtD
Methotrexate—Erythema multiforme—Ifosfamide—germ cell cancer	0.000107	0.00111	CcSEcCtD
Methotrexate—Ill-defined disorder—Bleomycin—germ cell cancer	0.000107	0.00111	CcSEcCtD
Methotrexate—Renal failure—Cisplatin—germ cell cancer	0.000107	0.00111	CcSEcCtD
Methotrexate—Anaemia—Bleomycin—germ cell cancer	0.000106	0.00111	CcSEcCtD
Methotrexate—ABCC3—endocrine gland—germ cell cancer	0.000106	0.00167	CbGeAlD
Methotrexate—Anorexia—Vinblastine—germ cell cancer	0.000106	0.00111	CcSEcCtD
Methotrexate—Pancytopenia—Etoposide—germ cell cancer	0.000106	0.0011	CcSEcCtD
Methotrexate—Stomatitis—Cisplatin—germ cell cancer	0.000106	0.0011	CcSEcCtD
Methotrexate—ABCC10—endocrine gland—germ cell cancer	0.000106	0.00167	CbGeAlD
Methotrexate—Eye disorder—Ifosfamide—germ cell cancer	0.000105	0.0011	CcSEcCtD
Methotrexate—Conjunctivitis—Cisplatin—germ cell cancer	0.000105	0.0011	CcSEcCtD
Methotrexate—Tinnitus—Ifosfamide—germ cell cancer	0.000105	0.0011	CcSEcCtD
Methotrexate—ABCC3—head—germ cell cancer	0.000105	0.00165	CbGeAlD
Methotrexate—Cardiac disorder—Ifosfamide—germ cell cancer	0.000105	0.00109	CcSEcCtD
Methotrexate—ALB—adrenal gland—germ cell cancer	0.000104	0.00165	CbGeAlD
Methotrexate—Neutropenia—Etoposide—germ cell cancer	0.000104	0.00109	CcSEcCtD
Methotrexate—SLC22A6—brain—germ cell cancer	0.000104	0.00164	CbGeAlD
Methotrexate—Malaise—Bleomycin—germ cell cancer	0.000104	0.00108	CcSEcCtD
Methotrexate—SLCO1A2—midbrain—germ cell cancer	0.000104	0.00164	CbGeAlD
Methotrexate—AOX1—testis—germ cell cancer	0.000104	0.00163	CbGeAlD
Methotrexate—Leukopenia—Bleomycin—germ cell cancer	0.000103	0.00107	CcSEcCtD
Methotrexate—Hepatobiliary disease—Cisplatin—germ cell cancer	0.000103	0.00107	CcSEcCtD
Methotrexate—Angiopathy—Ifosfamide—germ cell cancer	0.000102	0.00107	CcSEcCtD
Methotrexate—Immune system disorder—Ifosfamide—germ cell cancer	0.000102	0.00106	CcSEcCtD
Methotrexate—Mediastinal disorder—Ifosfamide—germ cell cancer	0.000102	0.00106	CcSEcCtD
Methotrexate—MTHFR—brain—germ cell cancer	0.000101	0.0016	CbGeAlD
Methotrexate—SLC16A1—cerebellum—germ cell cancer	0.000101	0.0016	CbGeAlD
Methotrexate—Chills—Ifosfamide—germ cell cancer	0.000101	0.00106	CcSEcCtD
Methotrexate—ABCC3—testis—germ cell cancer	0.000101	0.0016	CbGeAlD
Methotrexate—SLCO1A2—spinal cord—germ cell cancer	0.000101	0.0016	CbGeAlD
Methotrexate—ABCC4—adrenal gland—germ cell cancer	0.000101	0.00159	CbGeAlD
Methotrexate—ABCC10—testis—germ cell cancer	0.000101	0.00159	CbGeAlD
Methotrexate—Cough—Bleomycin—germ cell cancer	0.0001	0.00105	CcSEcCtD
Methotrexate—Pneumonia—Etoposide—germ cell cancer	9.99e-05	0.00104	CcSEcCtD
Methotrexate—SLCO3A1—brain—germ cell cancer	9.99e-05	0.00158	CbGeAlD
Methotrexate—Paraesthesia—Vinblastine—germ cell cancer	9.98e-05	0.00104	CcSEcCtD
Methotrexate—Alopecia—Ifosfamide—germ cell cancer	9.97e-05	0.00104	CcSEcCtD
Methotrexate—ABCB1—blood vessel—germ cell cancer	9.97e-05	0.00157	CbGeAlD
Methotrexate—Ill-defined disorder—Dactinomycin—germ cell cancer	9.95e-05	0.00104	CcSEcCtD
Methotrexate—Infestation—Etoposide—germ cell cancer	9.93e-05	0.00104	CcSEcCtD
Methotrexate—Infestation NOS—Etoposide—germ cell cancer	9.93e-05	0.00104	CcSEcCtD
Methotrexate—Anaemia—Dactinomycin—germ cell cancer	9.91e-05	0.00104	CcSEcCtD
Methotrexate—Mental disorder—Ifosfamide—germ cell cancer	9.89e-05	0.00103	CcSEcCtD
Methotrexate—Stevens-Johnson syndrome—Etoposide—germ cell cancer	9.85e-05	0.00103	CcSEcCtD
Methotrexate—Erythema—Ifosfamide—germ cell cancer	9.83e-05	0.00103	CcSEcCtD
Methotrexate—Malnutrition—Ifosfamide—germ cell cancer	9.83e-05	0.00103	CcSEcCtD
Methotrexate—ABCC1—uterus—germ cell cancer	9.82e-05	0.00155	CbGeAlD
Methotrexate—ABCG2—telencephalon—germ cell cancer	9.81e-05	0.00155	CbGeAlD
Methotrexate—MTHFR—lymph node—germ cell cancer	9.81e-05	0.00155	CbGeAlD
Methotrexate—Chest pain—Bleomycin—germ cell cancer	9.79e-05	0.00102	CcSEcCtD
Methotrexate—Myalgia—Bleomycin—germ cell cancer	9.79e-05	0.00102	CcSEcCtD
Methotrexate—ABCC2—adrenal gland—germ cell cancer	9.78e-05	0.00154	CbGeAlD
Methotrexate—ABCC4—bone marrow—germ cell cancer	9.78e-05	0.00154	CbGeAlD
Methotrexate—Renal failure—Etoposide—germ cell cancer	9.76e-05	0.00102	CcSEcCtD
Methotrexate—Stomatitis—Etoposide—germ cell cancer	9.68e-05	0.00101	CcSEcCtD
Methotrexate—Discomfort—Bleomycin—germ cell cancer	9.67e-05	0.00101	CcSEcCtD
Methotrexate—Malaise—Dactinomycin—germ cell cancer	9.67e-05	0.00101	CcSEcCtD
Methotrexate—Decreased appetite—Vinblastine—germ cell cancer	9.66e-05	0.00101	CcSEcCtD
Methotrexate—SLCO3A1—lymph node—germ cell cancer	9.65e-05	0.00152	CbGeAlD
Methotrexate—ABCC1—pituitary gland—germ cell cancer	9.65e-05	0.00152	CbGeAlD
Methotrexate—Urinary tract disorder—Cisplatin—germ cell cancer	9.61e-05	0.001	CcSEcCtD
Methotrexate—Leukopenia—Dactinomycin—germ cell cancer	9.6e-05	0.001	CcSEcCtD
Methotrexate—AOX1—cerebellum—germ cell cancer	9.56e-05	0.00151	CbGeAlD
Methotrexate—Urethral disorder—Cisplatin—germ cell cancer	9.54e-05	0.000996	CcSEcCtD
Methotrexate—Pain—Vinblastine—germ cell cancer	9.5e-05	0.000992	CcSEcCtD
Methotrexate—Confusional state—Bleomycin—germ cell cancer	9.46e-05	0.000988	CcSEcCtD
Methotrexate—ABCC4—female gonad—germ cell cancer	9.42e-05	0.00149	CbGeAlD
Methotrexate—Hepatobiliary disease—Etoposide—germ cell cancer	9.39e-05	0.000981	CcSEcCtD
Methotrexate—Anaphylactic shock—Bleomycin—germ cell cancer	9.38e-05	0.00098	CcSEcCtD
Methotrexate—Visual impairment—Cisplatin—germ cell cancer	9.38e-05	0.000979	CcSEcCtD
Methotrexate—Infection—Bleomycin—germ cell cancer	9.32e-05	0.000974	CcSEcCtD
Methotrexate—ABCC10—cerebellum—germ cell cancer	9.3e-05	0.00147	CbGeAlD
Methotrexate—ABCG2—decidua—germ cell cancer	9.3e-05	0.00147	CbGeAlD
Methotrexate—Agranulocytosis—Etoposide—germ cell cancer	9.27e-05	0.000968	CcSEcCtD
Methotrexate—TYMS—brain—germ cell cancer	9.26e-05	0.00146	CbGeAlD
Methotrexate—Vision blurred—Ifosfamide—germ cell cancer	9.26e-05	0.000967	CcSEcCtD
Methotrexate—Thrombocytopenia—Bleomycin—germ cell cancer	9.19e-05	0.000959	CcSEcCtD
Methotrexate—DHFR—brain—germ cell cancer	9.17e-05	0.00145	CbGeAlD
Methotrexate—Feeling abnormal—Vinblastine—germ cell cancer	9.15e-05	0.000956	CcSEcCtD
Methotrexate—Myalgia—Dactinomycin—germ cell cancer	9.13e-05	0.000953	CcSEcCtD
Methotrexate—Ill-defined disorder—Ifosfamide—germ cell cancer	9.12e-05	0.000952	CcSEcCtD
Methotrexate—SLCO1A2—endocrine gland—germ cell cancer	9.11e-05	0.00144	CbGeAlD
Methotrexate—Eye disorder—Cisplatin—germ cell cancer	9.09e-05	0.00095	CcSEcCtD
Methotrexate—Gastrointestinal pain—Vinblastine—germ cell cancer	9.08e-05	0.000949	CcSEcCtD
Methotrexate—Anaemia—Ifosfamide—germ cell cancer	9.08e-05	0.000948	CcSEcCtD
Methotrexate—Tinnitus—Cisplatin—germ cell cancer	9.07e-05	0.000948	CcSEcCtD
Methotrexate—Cardiac disorder—Cisplatin—germ cell cancer	9.03e-05	0.000943	CcSEcCtD
Methotrexate—Discomfort—Dactinomycin—germ cell cancer	9.02e-05	0.000942	CcSEcCtD
Methotrexate—SLCO1A2—head—germ cell cancer	8.99e-05	0.00142	CbGeAlD
Methotrexate—TYMS—lymph node—germ cell cancer	8.95e-05	0.00141	CbGeAlD
Methotrexate—Anorexia—Bleomycin—germ cell cancer	8.94e-05	0.000934	CcSEcCtD
Methotrexate—Malaise—Ifosfamide—germ cell cancer	8.86e-05	0.000925	CcSEcCtD
Methotrexate—DHFR—lymph node—germ cell cancer	8.86e-05	0.0014	CbGeAlD
Methotrexate—Vertigo—Ifosfamide—germ cell cancer	8.83e-05	0.000922	CcSEcCtD
Methotrexate—PGD—brain—germ cell cancer	8.81e-05	0.00139	CbGeAlD
Methotrexate—Urinary tract disorder—Etoposide—germ cell cancer	8.8e-05	0.000919	CcSEcCtD
Methotrexate—Leukopenia—Ifosfamide—germ cell cancer	8.79e-05	0.000919	CcSEcCtD
Methotrexate—Immune system disorder—Cisplatin—germ cell cancer	8.79e-05	0.000918	CcSEcCtD
Methotrexate—Abdominal pain—Vinblastine—germ cell cancer	8.78e-05	0.000917	CcSEcCtD
Methotrexate—Mediastinal disorder—Cisplatin—germ cell cancer	8.77e-05	0.000916	CcSEcCtD
Methotrexate—Hypotension—Bleomycin—germ cell cancer	8.77e-05	0.000916	CcSEcCtD
Methotrexate—ABCC4—endocrine gland—germ cell cancer	8.76e-05	0.00138	CbGeAlD
Methotrexate—Urethral disorder—Etoposide—germ cell cancer	8.74e-05	0.000913	CcSEcCtD
Methotrexate—Infection—Dactinomycin—germ cell cancer	8.69e-05	0.000908	CcSEcCtD
Methotrexate—SLCO1A2—testis—germ cell cancer	8.68e-05	0.00137	CbGeAlD
Methotrexate—ABCC4—head—germ cell cancer	8.65e-05	0.00136	CbGeAlD
Methotrexate—ALB—testis—germ cell cancer	8.63e-05	0.00136	CbGeAlD
Methotrexate—ABCC1—adrenal gland—germ cell cancer	8.62e-05	0.00136	CbGeAlD
Methotrexate—Alopecia—Cisplatin—germ cell cancer	8.6e-05	0.000898	CcSEcCtD
Methotrexate—SLC22A8—head—germ cell cancer	8.58e-05	0.00135	CbGeAlD
Methotrexate—Cough—Ifosfamide—germ cell cancer	8.57e-05	0.000895	CcSEcCtD
Methotrexate—Thrombocytopenia—Dactinomycin—germ cell cancer	8.57e-05	0.000895	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Bleomycin—germ cell cancer	8.55e-05	0.000893	CcSEcCtD
Methotrexate—PGD—lymph node—germ cell cancer	8.52e-05	0.00134	CbGeAlD
Methotrexate—Convulsion—Ifosfamide—germ cell cancer	8.51e-05	0.000889	CcSEcCtD
Methotrexate—ABCC2—endocrine gland—germ cell cancer	8.48e-05	0.00134	CbGeAlD
Methotrexate—Erythema—Cisplatin—germ cell cancer	8.47e-05	0.000885	CcSEcCtD
Methotrexate—Malnutrition—Cisplatin—germ cell cancer	8.47e-05	0.000885	CcSEcCtD
Methotrexate—Erythema multiforme—Etoposide—germ cell cancer	8.43e-05	0.00088	CcSEcCtD
Methotrexate—Paraesthesia—Bleomycin—germ cell cancer	8.43e-05	0.00088	CcSEcCtD
Methotrexate—Dyspnoea—Bleomycin—germ cell cancer	8.37e-05	0.000874	CcSEcCtD
Methotrexate—Arthralgia—Ifosfamide—germ cell cancer	8.36e-05	0.000874	CcSEcCtD
Methotrexate—Chest pain—Ifosfamide—germ cell cancer	8.36e-05	0.000874	CcSEcCtD
Methotrexate—Myalgia—Ifosfamide—germ cell cancer	8.36e-05	0.000874	CcSEcCtD
Methotrexate—ABCC4—testis—germ cell cancer	8.36e-05	0.00132	CbGeAlD
Methotrexate—Anorexia—Dactinomycin—germ cell cancer	8.34e-05	0.000871	CcSEcCtD
Methotrexate—Eye disorder—Etoposide—germ cell cancer	8.33e-05	0.00087	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	8.31e-05	0.000868	CcSEcCtD
Methotrexate—Cardiac disorder—Etoposide—germ cell cancer	8.27e-05	0.000864	CcSEcCtD
Methotrexate—Discomfort—Ifosfamide—germ cell cancer	8.26e-05	0.000863	CcSEcCtD
Methotrexate—SLC16A1—brain—germ cell cancer	8.23e-05	0.0013	CbGeAlD
Methotrexate—Hypersensitivity—Vinblastine—germ cell cancer	8.18e-05	0.000855	CcSEcCtD
Methotrexate—Decreased appetite—Bleomycin—germ cell cancer	8.16e-05	0.000852	CcSEcCtD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	8.14e-05	0.00194	CbGpPWpGaD
Methotrexate—ABCG2—uterus—germ cell cancer	8.13e-05	0.00128	CbGeAlD
Methotrexate—SLCO1C1—SLC-mediated transmembrane transport—AVP—germ cell cancer	8.11e-05	0.00193	CbGpPWpGaD
Methotrexate—ABCC2—testis—germ cell cancer	8.09e-05	0.00128	CbGeAlD
Methotrexate—Angiopathy—Etoposide—germ cell cancer	8.09e-05	0.000845	CcSEcCtD
Methotrexate—Confusional state—Ifosfamide—germ cell cancer	8.09e-05	0.000844	CcSEcCtD
Methotrexate—Immune system disorder—Etoposide—germ cell cancer	8.05e-05	0.000841	CcSEcCtD
Methotrexate—ABCC1—female gonad—germ cell cancer	8.03e-05	0.00127	CbGeAlD
Methotrexate—Mediastinal disorder—Etoposide—germ cell cancer	8.03e-05	0.000839	CcSEcCtD
Methotrexate—Pain—Bleomycin—germ cell cancer	8.02e-05	0.000838	CcSEcCtD
Methotrexate—SLCO1A2—cerebellum—germ cell cancer	8.02e-05	0.00127	CbGeAlD
Methotrexate—Anaphylactic shock—Ifosfamide—germ cell cancer	8.02e-05	0.000838	CcSEcCtD
Methotrexate—Chills—Etoposide—germ cell cancer	8e-05	0.000835	CcSEcCtD
Methotrexate—ABCG2—pituitary gland—germ cell cancer	7.99e-05	0.00126	CbGeAlD
Methotrexate—Vision blurred—Cisplatin—germ cell cancer	7.98e-05	0.000834	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	7.97e-05	0.000833	CcSEcCtD
Methotrexate—Asthenia—Vinblastine—germ cell cancer	7.97e-05	0.000832	CcSEcCtD
Methotrexate—Infection—Ifosfamide—germ cell cancer	7.97e-05	0.000832	CcSEcCtD
Methotrexate—SLC22A7—Fluoropyrimidine Activity—TP53—germ cell cancer	7.95e-05	0.00189	CbGpPWpGaD
Methotrexate—SLC16A1—lymph node—germ cell cancer	7.95e-05	0.00125	CbGeAlD
Methotrexate—Alopecia—Etoposide—germ cell cancer	7.88e-05	0.000823	CcSEcCtD
Methotrexate—Nervous system disorder—Ifosfamide—germ cell cancer	7.86e-05	0.000821	CcSEcCtD
Methotrexate—Ill-defined disorder—Cisplatin—germ cell cancer	7.86e-05	0.000821	CcSEcCtD
Methotrexate—Thrombocytopenia—Ifosfamide—germ cell cancer	7.85e-05	0.00082	CcSEcCtD
Methotrexate—Anaemia—Cisplatin—germ cell cancer	7.83e-05	0.000818	CcSEcCtD
Methotrexate—SLCO1A2—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	7.82e-05	0.00186	CbGpPWpGaD
Methotrexate—Skin disorder—Ifosfamide—germ cell cancer	7.79e-05	0.000813	CcSEcCtD
Methotrexate—AOX1—brain—germ cell cancer	7.77e-05	0.00123	CbGeAlD
Methotrexate—Hyperhidrosis—Ifosfamide—germ cell cancer	7.75e-05	0.00081	CcSEcCtD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	7.73e-05	0.00184	CbGpPWpGaD
Methotrexate—Feeling abnormal—Bleomycin—germ cell cancer	7.73e-05	0.000808	CcSEcCtD
Methotrexate—ABCG2—medulla oblongata—germ cell cancer	7.71e-05	0.00122	CbGeAlD
Methotrexate—SLCO1A2—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	7.7e-05	0.00183	CbGpPWpGaD
Methotrexate—Anorexia—Ifosfamide—germ cell cancer	7.64e-05	0.000798	CcSEcCtD
Methotrexate—Malaise—Cisplatin—germ cell cancer	7.64e-05	0.000798	CcSEcCtD
Methotrexate—Decreased appetite—Dactinomycin—germ cell cancer	7.61e-05	0.000794	CcSEcCtD
Methotrexate—Diarrhoea—Vinblastine—germ cell cancer	7.6e-05	0.000794	CcSEcCtD
Methotrexate—Dysgeusia—Etoposide—germ cell cancer	7.6e-05	0.000794	CcSEcCtD
Methotrexate—ABCC3—brain—germ cell cancer	7.6e-05	0.0012	CbGeAlD
Methotrexate—Leukopenia—Cisplatin—germ cell cancer	7.58e-05	0.000792	CcSEcCtD
Methotrexate—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	7.58e-05	0.0018	CbGpPWpGaD
Methotrexate—ABCC10—brain—germ cell cancer	7.56e-05	0.00119	CbGeAlD
Methotrexate—Fatigue—Dactinomycin—germ cell cancer	7.54e-05	0.000788	CcSEcCtD
Methotrexate—Back pain—Etoposide—germ cell cancer	7.51e-05	0.000784	CcSEcCtD
Methotrexate—AOX1—lymph node—germ cell cancer	7.5e-05	0.00118	CbGeAlD
Methotrexate—Hypotension—Ifosfamide—germ cell cancer	7.49e-05	0.000783	CcSEcCtD
Methotrexate—Pain—Dactinomycin—germ cell cancer	7.48e-05	0.000782	CcSEcCtD
Methotrexate—Urticaria—Bleomycin—germ cell cancer	7.45e-05	0.000778	CcSEcCtD
Methotrexate—Body temperature increased—Bleomycin—germ cell cancer	7.42e-05	0.000775	CcSEcCtD
Methotrexate—SLC22A6—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	7.35e-05	0.00175	CbGpPWpGaD
Methotrexate—Dizziness—Vinblastine—germ cell cancer	7.35e-05	0.000767	CcSEcCtD
Methotrexate—Convulsion—Cisplatin—germ cell cancer	7.34e-05	0.000767	CcSEcCtD
Methotrexate—ABCC3—lymph node—germ cell cancer	7.34e-05	0.00116	CbGeAlD
Methotrexate—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	7.31e-05	0.000763	CcSEcCtD
Methotrexate—ABCC10—lymph node—germ cell cancer	7.3e-05	0.00115	CbGeAlD
Methotrexate—SLC22A6—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	7.24e-05	0.00172	CbGpPWpGaD
Methotrexate—Myalgia—Cisplatin—germ cell cancer	7.21e-05	0.000753	CcSEcCtD
Methotrexate—Feeling abnormal—Dactinomycin—germ cell cancer	7.21e-05	0.000753	CcSEcCtD
Methotrexate—Paraesthesia—Ifosfamide—germ cell cancer	7.2e-05	0.000752	CcSEcCtD
Methotrexate—Ill-defined disorder—Etoposide—germ cell cancer	7.2e-05	0.000752	CcSEcCtD
Methotrexate—Anaemia—Etoposide—germ cell cancer	7.17e-05	0.000749	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	7.16e-05	0.000748	CcSEcCtD
Methotrexate—Gastrointestinal pain—Dactinomycin—germ cell cancer	7.16e-05	0.000747	CcSEcCtD
Methotrexate—Dyspnoea—Ifosfamide—germ cell cancer	7.15e-05	0.000747	CcSEcCtD
Methotrexate—ABCG2—adrenal gland—germ cell cancer	7.13e-05	0.00113	CbGeAlD
Methotrexate—Somnolence—Ifosfamide—germ cell cancer	7.13e-05	0.000745	CcSEcCtD
Methotrexate—ABCC1—testis—germ cell cancer	7.13e-05	0.00112	CbGeAlD
Methotrexate—Discomfort—Cisplatin—germ cell cancer	7.13e-05	0.000744	CcSEcCtD
Methotrexate—ATIC—Metabolism—SLC2A3—germ cell cancer	7.09e-05	0.00169	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—SLC2A3—germ cell cancer	7.09e-05	0.00169	CbGpPWpGaD
Methotrexate—Vomiting—Vinblastine—germ cell cancer	7.06e-05	0.000738	CcSEcCtD
Methotrexate—ABCG2—midbrain—germ cell cancer	7.04e-05	0.00111	CbGeAlD
Methotrexate—Malaise—Etoposide—germ cell cancer	7e-05	0.000731	CcSEcCtD
Methotrexate—ATIC—Metabolism—SLC22A3—germ cell cancer	6.98e-05	0.00166	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—SLC22A3—germ cell cancer	6.98e-05	0.00166	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	6.98e-05	0.00166	CbGpPWpGaD
Methotrexate—Vertigo—Etoposide—germ cell cancer	6.97e-05	0.000728	CcSEcCtD
Methotrexate—Decreased appetite—Ifosfamide—germ cell cancer	6.97e-05	0.000728	CcSEcCtD
Methotrexate—Headache—Vinblastine—germ cell cancer	6.96e-05	0.000727	CcSEcCtD
Methotrexate—Leukopenia—Etoposide—germ cell cancer	6.95e-05	0.000725	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Ifosfamide—germ cell cancer	6.92e-05	0.000723	CcSEcCtD
Methotrexate—Abdominal pain—Dactinomycin—germ cell cancer	6.92e-05	0.000722	CcSEcCtD
Methotrexate—Body temperature increased—Dactinomycin—germ cell cancer	6.92e-05	0.000722	CcSEcCtD
Methotrexate—Fatigue—Ifosfamide—germ cell cancer	6.91e-05	0.000722	CcSEcCtD
Methotrexate—Anaphylactic shock—Cisplatin—germ cell cancer	6.91e-05	0.000722	CcSEcCtD
Methotrexate—Hypersensitivity—Bleomycin—germ cell cancer	6.91e-05	0.000722	CcSEcCtD
Methotrexate—ABCG2—bone marrow—germ cell cancer	6.9e-05	0.00109	CbGeAlD
Methotrexate—ABCG2—spinal cord—germ cell cancer	6.87e-05	0.00108	CbGeAlD
Methotrexate—Infection—Cisplatin—germ cell cancer	6.87e-05	0.000717	CcSEcCtD
Methotrexate—Pain—Ifosfamide—germ cell cancer	6.86e-05	0.000716	CcSEcCtD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	6.84e-05	0.00163	CbGpPWpGaD
Methotrexate—ABCC3—Fluoropyrimidine Activity—TP53—germ cell cancer	6.81e-05	0.00162	CbGpPWpGaD
Methotrexate—Nervous system disorder—Cisplatin—germ cell cancer	6.78e-05	0.000708	CcSEcCtD
Methotrexate—Cough—Etoposide—germ cell cancer	6.77e-05	0.000707	CcSEcCtD
Methotrexate—Thrombocytopenia—Cisplatin—germ cell cancer	6.77e-05	0.000707	CcSEcCtD
Methotrexate—Asthenia—Bleomycin—germ cell cancer	6.73e-05	0.000703	CcSEcCtD
Methotrexate—Convulsion—Etoposide—germ cell cancer	6.72e-05	0.000702	CcSEcCtD
Methotrexate—Skin disorder—Cisplatin—germ cell cancer	6.71e-05	0.000701	CcSEcCtD
Methotrexate—SLC19A1—Metabolism—CRABP1—germ cell cancer	6.69e-05	0.00159	CbGpPWpGaD
Methotrexate—SLCO1B1—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	6.69e-05	0.00159	CbGpPWpGaD
Methotrexate—Hyperhidrosis—Cisplatin—germ cell cancer	6.68e-05	0.000698	CcSEcCtD
Methotrexate—ABCG2—female gonad—germ cell cancer	6.65e-05	0.00105	CbGeAlD
Methotrexate—Pruritus—Bleomycin—germ cell cancer	6.64e-05	0.000693	CcSEcCtD
Methotrexate—Feeling abnormal—Ifosfamide—germ cell cancer	6.61e-05	0.00069	CcSEcCtD
Methotrexate—Chest pain—Etoposide—germ cell cancer	6.61e-05	0.00069	CcSEcCtD
Methotrexate—Nausea—Vinblastine—germ cell cancer	6.6e-05	0.000689	CcSEcCtD
Methotrexate—SLC46A1—Disease—SLC2A3—germ cell cancer	6.59e-05	0.00157	CbGpPWpGaD
Methotrexate—Anorexia—Cisplatin—germ cell cancer	6.59e-05	0.000688	CcSEcCtD
Methotrexate—SLCO1B1—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	6.59e-05	0.00157	CbGpPWpGaD
Methotrexate—ABCC1—cerebellum—germ cell cancer	6.58e-05	0.00104	CbGeAlD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	6.56e-05	0.000685	CcSEcCtD
Methotrexate—ABCC4—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	6.56e-05	0.00156	CbGpPWpGaD
Methotrexate—Gastrointestinal pain—Ifosfamide—germ cell cancer	6.56e-05	0.000685	CcSEcCtD
Methotrexate—Discomfort—Etoposide—germ cell cancer	6.53e-05	0.000682	CcSEcCtD
Methotrexate—SLCO1A2—brain—germ cell cancer	6.51e-05	0.00103	CbGeAlD
Methotrexate—ALB—brain—germ cell cancer	6.48e-05	0.00102	CbGeAlD
Methotrexate—Hypotension—Cisplatin—germ cell cancer	6.46e-05	0.000675	CcSEcCtD
Methotrexate—SLC16A1—Hemostasis—CD9—germ cell cancer	6.46e-05	0.00154	CbGpPWpGaD
Methotrexate—Hypersensitivity—Dactinomycin—germ cell cancer	6.45e-05	0.000673	CcSEcCtD
Methotrexate—ABCC4—Fluoropyrimidine Activity—TP53—germ cell cancer	6.41e-05	0.00153	CbGpPWpGaD
Methotrexate—Confusional state—Etoposide—germ cell cancer	6.39e-05	0.000667	CcSEcCtD
Methotrexate—Urticaria—Ifosfamide—germ cell cancer	6.37e-05	0.000665	CcSEcCtD
Methotrexate—Abdominal pain—Ifosfamide—germ cell cancer	6.34e-05	0.000662	CcSEcCtD
Methotrexate—Body temperature increased—Ifosfamide—germ cell cancer	6.34e-05	0.000662	CcSEcCtD
Methotrexate—Anaphylactic shock—Etoposide—germ cell cancer	6.33e-05	0.000661	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Cisplatin—germ cell cancer	6.3e-05	0.000658	CcSEcCtD
Methotrexate—Infection—Etoposide—germ cell cancer	6.29e-05	0.000657	CcSEcCtD
Methotrexate—Asthenia—Dactinomycin—germ cell cancer	6.28e-05	0.000656	CcSEcCtD
Methotrexate—ABCC4—brain—germ cell cancer	6.27e-05	0.000989	CbGeAlD
Methotrexate—ALB—lymph node—germ cell cancer	6.26e-05	0.000987	CbGeAlD
Methotrexate—SLC22A8—brain—germ cell cancer	6.22e-05	0.000981	CbGeAlD
Methotrexate—Paraesthesia—Cisplatin—germ cell cancer	6.21e-05	0.000648	CcSEcCtD
Methotrexate—Thrombocytopenia—Etoposide—germ cell cancer	6.2e-05	0.000648	CcSEcCtD
Methotrexate—Dyspnoea—Cisplatin—germ cell cancer	6.16e-05	0.000644	CcSEcCtD
Methotrexate—ABCB1—trigeminal ganglion—germ cell cancer	6.16e-05	0.000971	CbGeAlD
Methotrexate—Skin disorder—Etoposide—germ cell cancer	6.15e-05	0.000643	CcSEcCtD
Methotrexate—TYMS—Circadian rythm related genes—AVP—germ cell cancer	6.15e-05	0.00146	CbGpPWpGaD
Methotrexate—Hyperhidrosis—Etoposide—germ cell cancer	6.12e-05	0.000639	CcSEcCtD
Methotrexate—MTHFR—Folate Metabolism—TP53—germ cell cancer	6.1e-05	0.00145	CbGpPWpGaD
Methotrexate—DHFR—E2F transcription factor network—MYC—germ cell cancer	6.09e-05	0.00145	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	6.08e-05	0.00145	CbGpPWpGaD
Methotrexate—ABCC4—lymph node—germ cell cancer	6.06e-05	0.000956	CbGeAlD
Methotrexate—Anorexia—Etoposide—germ cell cancer	6.04e-05	0.000631	CcSEcCtD
Methotrexate—PGD—Disease—SLC2A3—germ cell cancer	6.03e-05	0.00144	CbGpPWpGaD
Methotrexate—Decreased appetite—Cisplatin—germ cell cancer	6.01e-05	0.000628	CcSEcCtD
Methotrexate—Diarrhoea—Dactinomycin—germ cell cancer	5.99e-05	0.000625	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Cisplatin—germ cell cancer	5.97e-05	0.000623	CcSEcCtD
Methotrexate—Vomiting—Bleomycin—germ cell cancer	5.97e-05	0.000623	CcSEcCtD
Methotrexate—ABCB1—embryo—germ cell cancer	5.95e-05	0.000938	CbGeAlD
Methotrexate—Hypotension—Etoposide—germ cell cancer	5.92e-05	0.000618	CcSEcCtD
Methotrexate—Rash—Bleomycin—germ cell cancer	5.92e-05	0.000618	CcSEcCtD
Methotrexate—Pain—Cisplatin—germ cell cancer	5.91e-05	0.000617	CcSEcCtD
Methotrexate—Dermatitis—Bleomycin—germ cell cancer	5.91e-05	0.000617	CcSEcCtD
Methotrexate—Hypersensitivity—Ifosfamide—germ cell cancer	5.91e-05	0.000617	CcSEcCtD
Methotrexate—ABCG2—testis—germ cell cancer	5.9e-05	0.000931	CbGeAlD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	5.87e-05	0.0014	CbGpPWpGaD
Methotrexate—ABCC2—lymph node—germ cell cancer	5.86e-05	0.000925	CbGeAlD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	5.78e-05	0.00138	CbGpPWpGaD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	5.76e-05	0.00137	CbGpPWpGaD
Methotrexate—Asthenia—Ifosfamide—germ cell cancer	5.75e-05	0.000601	CcSEcCtD
Methotrexate—SLC19A1—Disease—FGF4—germ cell cancer	5.72e-05	0.00136	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	5.71e-05	0.00136	CbGpPWpGaD
Methotrexate—Feeling abnormal—Cisplatin—germ cell cancer	5.7e-05	0.000595	CcSEcCtD
Methotrexate—ATIC—Metabolism—CRABP1—germ cell cancer	5.69e-05	0.00135	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—CRABP1—germ cell cancer	5.69e-05	0.00135	CbGpPWpGaD
Methotrexate—Paraesthesia—Etoposide—germ cell cancer	5.69e-05	0.000594	CcSEcCtD
Methotrexate—Pruritus—Ifosfamide—germ cell cancer	5.67e-05	0.000593	CcSEcCtD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	5.67e-05	0.00135	CbGpPWpGaD
Methotrexate—Dyspnoea—Etoposide—germ cell cancer	5.65e-05	0.00059	CcSEcCtD
Methotrexate—Somnolence—Etoposide—germ cell cancer	5.63e-05	0.000588	CcSEcCtD
Methotrexate—Nausea—Bleomycin—germ cell cancer	5.57e-05	0.000582	CcSEcCtD
Methotrexate—Vomiting—Dactinomycin—germ cell cancer	5.56e-05	0.000581	CcSEcCtD
Methotrexate—ABCC2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	5.53e-05	0.00132	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—SLC2A3—germ cell cancer	5.52e-05	0.00131	CbGpPWpGaD
Methotrexate—Rash—Dactinomycin—germ cell cancer	5.52e-05	0.000576	CcSEcCtD
Methotrexate—Decreased appetite—Etoposide—germ cell cancer	5.51e-05	0.000575	CcSEcCtD
Methotrexate—Diarrhoea—Ifosfamide—germ cell cancer	5.49e-05	0.000573	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Etoposide—germ cell cancer	5.47e-05	0.000571	CcSEcCtD
Methotrexate—ABCC1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	5.47e-05	0.0013	CbGpPWpGaD
Methotrexate—Body temperature increased—Cisplatin—germ cell cancer	5.46e-05	0.000571	CcSEcCtD
Methotrexate—Fatigue—Etoposide—germ cell cancer	5.46e-05	0.00057	CcSEcCtD
Methotrexate—ABCG2—cerebellum—germ cell cancer	5.45e-05	0.00086	CbGeAlD
Methotrexate—SLC46A1—Metabolism—SLC22A3—germ cell cancer	5.44e-05	0.00129	CbGpPWpGaD
Methotrexate—SLC46A1—Transmembrane transport of small molecules—AVP—germ cell cancer	5.44e-05	0.00129	CbGpPWpGaD
Methotrexate—ABCC10—Transmembrane transport of small molecules—AVP—germ cell cancer	5.44e-05	0.00129	CbGpPWpGaD
Methotrexate—DHFR—Folate Metabolism—TP53—germ cell cancer	5.42e-05	0.00129	CbGpPWpGaD
Methotrexate—Pain—Etoposide—germ cell cancer	5.42e-05	0.000566	CcSEcCtD
Methotrexate—ABCC1—brain—germ cell cancer	5.35e-05	0.000843	CbGeAlD
Methotrexate—SLC22A11—SLC-mediated transmembrane transport—AVP—germ cell cancer	5.33e-05	0.00127	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	5.33e-05	0.00127	CbGpPWpGaD
Methotrexate—TYMS—E2F transcription factor network—MYC—germ cell cancer	5.31e-05	0.00126	CbGpPWpGaD
Methotrexate—Dizziness—Ifosfamide—germ cell cancer	5.3e-05	0.000554	CcSEcCtD
Methotrexate—DHFR—Retinoblastoma (RB) in Cancer—MYC—germ cell cancer	5.29e-05	0.00126	CbGpPWpGaD
Methotrexate—ABCB1—retina—germ cell cancer	5.26e-05	0.000829	CbGeAlD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	5.25e-05	0.00125	CbGpPWpGaD
Methotrexate—SLC16A1—SLC-mediated transmembrane transport—AVP—germ cell cancer	5.22e-05	0.00124	CbGpPWpGaD
Methotrexate—Feeling abnormal—Etoposide—germ cell cancer	5.22e-05	0.000545	CcSEcCtD
Methotrexate—Nausea—Dactinomycin—germ cell cancer	5.2e-05	0.000543	CcSEcCtD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	5.2e-05	0.00124	CbGpPWpGaD
Methotrexate—Gastrointestinal pain—Etoposide—germ cell cancer	5.18e-05	0.000541	CcSEcCtD
Methotrexate—ABCC1—lymph node—germ cell cancer	5.17e-05	0.000815	CbGeAlD
Methotrexate—SLCO3A1—Transmembrane transport of small molecules—AVP—germ cell cancer	5.15e-05	0.00123	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—H2AFZ—germ cell cancer	5.1e-05	0.00122	CbGpPWpGaD
Methotrexate—Vomiting—Ifosfamide—germ cell cancer	5.1e-05	0.000533	CcSEcCtD
Methotrexate—Hypersensitivity—Cisplatin—germ cell cancer	5.09e-05	0.000532	CcSEcCtD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	5.06e-05	0.0012	CbGpPWpGaD
Methotrexate—Rash—Ifosfamide—germ cell cancer	5.06e-05	0.000528	CcSEcCtD
Methotrexate—Dermatitis—Ifosfamide—germ cell cancer	5.05e-05	0.000528	CcSEcCtD
Methotrexate—PGD—Metabolism—SLC2A3—germ cell cancer	5.05e-05	0.0012	CbGpPWpGaD
Methotrexate—Urticaria—Etoposide—germ cell cancer	5.03e-05	0.000525	CcSEcCtD
Methotrexate—Body temperature increased—Etoposide—germ cell cancer	5.01e-05	0.000523	CcSEcCtD
Methotrexate—Abdominal pain—Etoposide—germ cell cancer	5.01e-05	0.000523	CcSEcCtD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	4.98e-05	0.00119	CbGpPWpGaD
Methotrexate—PGD—Metabolism—SLC22A3—germ cell cancer	4.97e-05	0.00118	CbGpPWpGaD
Methotrexate—Asthenia—Cisplatin—germ cell cancer	4.96e-05	0.000518	CcSEcCtD
Methotrexate—SLCO4C1—Transmembrane transport of small molecules—AVP—germ cell cancer	4.92e-05	0.00117	CbGpPWpGaD
Methotrexate—FPGS—Disease—FGF4—germ cell cancer	4.86e-05	0.00116	CbGpPWpGaD
Methotrexate—ABCB1—telencephalon—germ cell cancer	4.84e-05	0.000763	CbGeAlD
Methotrexate—SLC22A7—SLC-mediated transmembrane transport—AVP—germ cell cancer	4.83e-05	0.00115	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—CD9—germ cell cancer	4.81e-05	0.00115	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	4.81e-05	0.00115	CbGpPWpGaD
Methotrexate—Nausea—Ifosfamide—germ cell cancer	4.76e-05	0.000497	CcSEcCtD
Methotrexate—Diarrhoea—Cisplatin—germ cell cancer	4.73e-05	0.000494	CcSEcCtD
Methotrexate—ABCG2—Fluoropyrimidine Activity—TP53—germ cell cancer	4.7e-05	0.00112	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—KITLG—germ cell cancer	4.7e-05	0.00112	CbGpPWpGaD
Methotrexate—Hypersensitivity—Etoposide—germ cell cancer	4.67e-05	0.000487	CcSEcCtD
Methotrexate—TYMS—Retinoblastoma (RB) in Cancer—MYC—germ cell cancer	4.62e-05	0.0011	CbGpPWpGaD
Methotrexate—SLCO1B3—SLC-mediated transmembrane transport—AVP—germ cell cancer	4.59e-05	0.00109	CbGpPWpGaD
Methotrexate—ABCB1—decidua—germ cell cancer	4.58e-05	0.000723	CbGeAlD
Methotrexate—ABCC3—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	4.56e-05	0.00109	CbGpPWpGaD
Methotrexate—Asthenia—Etoposide—germ cell cancer	4.54e-05	0.000475	CcSEcCtD
Methotrexate—ABCC3—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	4.5e-05	0.00107	CbGpPWpGaD
Methotrexate—Pruritus—Etoposide—germ cell cancer	4.48e-05	0.000468	CcSEcCtD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	4.48e-05	0.00107	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—CRABP1—germ cell cancer	4.43e-05	0.00106	CbGpPWpGaD
Methotrexate—ABCG2—brain—germ cell cancer	4.43e-05	0.000698	CbGeAlD
Methotrexate—DHFR—G1/S Transition—MYC—germ cell cancer	4.42e-05	0.00105	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	4.41e-05	0.00105	CbGpPWpGaD
Methotrexate—Vomiting—Cisplatin—germ cell cancer	4.4e-05	0.000459	CcSEcCtD
Methotrexate—Rash—Cisplatin—germ cell cancer	4.36e-05	0.000455	CcSEcCtD
Methotrexate—Dermatitis—Cisplatin—germ cell cancer	4.35e-05	0.000455	CcSEcCtD
Methotrexate—DHFR—Retinoblastoma (RB) in Cancer—TP53—germ cell cancer	4.34e-05	0.00103	CbGpPWpGaD
Methotrexate—FPGS—Disease—H2AFZ—germ cell cancer	4.34e-05	0.00103	CbGpPWpGaD
Methotrexate—Diarrhoea—Etoposide—germ cell cancer	4.33e-05	0.000453	CcSEcCtD
Methotrexate—ABCC4—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	4.29e-05	0.00102	CbGpPWpGaD
Methotrexate—ABCG2—lymph node—germ cell cancer	4.28e-05	0.000675	CbGeAlD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	4.27e-05	0.00102	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	4.23e-05	0.00101	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—CD9—germ cell cancer	4.23e-05	0.00101	CbGpPWpGaD
Methotrexate—Dizziness—Etoposide—germ cell cancer	4.19e-05	0.000437	CcSEcCtD
Methotrexate—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	4.17e-05	0.000993	CbGpPWpGaD
Methotrexate—SLCO1C1—Transmembrane transport of small molecules—AVP—germ cell cancer	4.12e-05	0.000981	CbGpPWpGaD
Methotrexate—Nausea—Cisplatin—germ cell cancer	4.11e-05	0.000429	CcSEcCtD
Methotrexate—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	4.1e-05	0.000975	CbGpPWpGaD
Methotrexate—SLC22A8—SLC-mediated transmembrane transport—AVP—germ cell cancer	4.06e-05	0.000967	CbGpPWpGaD
Methotrexate—PGD—Metabolism—CRABP1—germ cell cancer	4.05e-05	0.000965	CbGpPWpGaD
Methotrexate—ABCB1—gonad—germ cell cancer	4.04e-05	0.000637	CbGeAlD
Methotrexate—Vomiting—Etoposide—germ cell cancer	4.03e-05	0.000421	CcSEcCtD
Methotrexate—ABCB1—uterus—germ cell cancer	4.01e-05	0.000633	CbGeAlD
Methotrexate—Rash—Etoposide—germ cell cancer	3.99e-05	0.000417	CcSEcCtD
Methotrexate—FPGS—Disease—KITLG—germ cell cancer	3.99e-05	0.000951	CbGpPWpGaD
Methotrexate—Dermatitis—Etoposide—germ cell cancer	3.99e-05	0.000417	CcSEcCtD
Methotrexate—MTHFR—Disease—SLC2A3—germ cell cancer	3.98e-05	0.000947	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	3.97e-05	0.000946	CbGpPWpGaD
Methotrexate—Headache—Etoposide—germ cell cancer	3.97e-05	0.000414	CcSEcCtD
Methotrexate—DHFR—Cell Cycle, Mitotic—H2AFZ—germ cell cancer	3.95e-05	0.000941	CbGpPWpGaD
Methotrexate—ABCB1—pituitary gland—germ cell cancer	3.94e-05	0.000621	CbGeAlD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	3.92e-05	0.000932	CbGpPWpGaD
Methotrexate—AOX1—Disease—SLC2A3—germ cell cancer	3.89e-05	0.000925	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	3.85e-05	0.000918	CbGpPWpGaD
Methotrexate—TYMS—G1/S Transition—MYC—germ cell cancer	3.85e-05	0.000918	CbGpPWpGaD
Methotrexate—ALB—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	3.82e-05	0.00091	CbGpPWpGaD
Methotrexate—ABCB1—medulla oblongata—germ cell cancer	3.8e-05	0.000599	CbGeAlD
Methotrexate—TYMS—Retinoblastoma (RB) in Cancer—TP53—germ cell cancer	3.79e-05	0.000902	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—FGF4—germ cell cancer	3.79e-05	0.000901	CbGpPWpGaD
Methotrexate—ALB—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	3.76e-05	0.000896	CbGpPWpGaD
Methotrexate—Nausea—Etoposide—germ cell cancer	3.76e-05	0.000393	CcSEcCtD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	3.74e-05	0.000889	CbGpPWpGaD
Methotrexate—DHFR—Mitotic G1-G1/S phases—MYC—germ cell cancer	3.72e-05	0.000886	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	3.68e-05	0.000876	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	3.62e-05	0.000862	CbGpPWpGaD
Methotrexate—SLCO1A2—SLC-mediated transmembrane transport—AVP—germ cell cancer	3.61e-05	0.000859	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	3.58e-05	0.000852	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	3.56e-05	0.000849	CbGpPWpGaD
Methotrexate—DHFR—Disease—SLC2A3—germ cell cancer	3.53e-05	0.000841	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle—H2AFZ—germ cell cancer	3.53e-05	0.000841	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	3.52e-05	0.000839	CbGpPWpGaD
Methotrexate—ABCB1—adrenal gland—germ cell cancer	3.52e-05	0.000555	CbGeAlD
Methotrexate—SLC19A1—Disease—FGFR3—germ cell cancer	3.49e-05	0.000831	CbGpPWpGaD
Methotrexate—ABCB1—midbrain—germ cell cancer	3.47e-05	0.000548	CbGeAlD
Methotrexate—PGD—Disease—FGF4—germ cell cancer	3.46e-05	0.000824	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle, Mitotic—H2AFZ—germ cell cancer	3.45e-05	0.000821	CbGpPWpGaD
Methotrexate—SLC16A1—Cell surface interactions at the vascular wall—HRAS—germ cell cancer	3.41e-05	0.000812	CbGpPWpGaD
Methotrexate—ABCB1—bone marrow—germ cell cancer	3.4e-05	0.000537	CbGeAlD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	3.4e-05	0.000809	CbGpPWpGaD
Methotrexate—SLC22A6—SLC-mediated transmembrane transport—AVP—germ cell cancer	3.39e-05	0.000807	CbGpPWpGaD
Methotrexate—ABCB1—spinal cord—germ cell cancer	3.39e-05	0.000535	CbGeAlD
Methotrexate—SLC46A1—Disease—H2AFZ—germ cell cancer	3.38e-05	0.000805	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	3.36e-05	0.000799	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	3.35e-05	0.000797	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—SLC2A3—germ cell cancer	3.33e-05	0.000793	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—SLC22A3—germ cell cancer	3.28e-05	0.000781	CbGpPWpGaD
Methotrexate—ABCB1—female gonad—germ cell cancer	3.28e-05	0.000517	CbGeAlD
Methotrexate—AOX1—Metabolism—SLC2A3—germ cell cancer	3.25e-05	0.000775	CbGpPWpGaD
Methotrexate—TYMS—Mitotic G1-G1/S phases—MYC—germ cell cancer	3.25e-05	0.000773	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—SLC22A3—germ cell cancer	3.2e-05	0.000763	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—KIT—germ cell cancer	3.2e-05	0.000763	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	3.15e-05	0.000749	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—KITLG—germ cell cancer	3.11e-05	0.000741	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	3.1e-05	0.000738	CbGpPWpGaD
Methotrexate—PGD—Disease—H2AFZ—germ cell cancer	3.09e-05	0.000736	CbGpPWpGaD
Methotrexate—SLCO1B1—SLC-mediated transmembrane transport—AVP—germ cell cancer	3.08e-05	0.000734	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle—H2AFZ—germ cell cancer	3.08e-05	0.000734	CbGpPWpGaD
Methotrexate—ABCB1—endocrine gland—germ cell cancer	3.05e-05	0.000481	CbGeAlD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	3.02e-05	0.000719	CbGpPWpGaD
Methotrexate—ABCB1—head—germ cell cancer	3.01e-05	0.000475	CbGeAlD
Methotrexate—ALB—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	2.97e-05	0.000707	CbGpPWpGaD
Methotrexate—FPGS—Disease—FGFR3—germ cell cancer	2.97e-05	0.000706	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—SLC2A3—germ cell cancer	2.96e-05	0.000705	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—SLC22A3—germ cell cancer	2.92e-05	0.000694	CbGpPWpGaD
Methotrexate—ABCB1—testis—germ cell cancer	2.91e-05	0.000459	CbGeAlD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	2.87e-05	0.000683	CbGpPWpGaD
Methotrexate—PGD—Disease—KITLG—germ cell cancer	2.84e-05	0.000677	CbGpPWpGaD
Methotrexate—FPGS—Disease—KIT—germ cell cancer	2.72e-05	0.000649	CbGpPWpGaD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—AVP—germ cell cancer	2.71e-05	0.000644	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—SLC2A3—germ cell cancer	2.7e-05	0.000642	CbGpPWpGaD
Methotrexate—ABCB1—cerebellum—germ cell cancer	2.69e-05	0.000424	CbGeAlD
Methotrexate—MTHFR—Metabolism—CRABP1—germ cell cancer	2.67e-05	0.000637	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—SLC22A3—germ cell cancer	2.66e-05	0.000632	CbGpPWpGaD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—AVP—germ cell cancer	2.65e-05	0.000632	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—CRABP1—germ cell cancer	2.61e-05	0.000622	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	2.6e-05	0.000619	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—SLC2A3—germ cell cancer	2.58e-05	0.000615	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—SLC22A3—germ cell cancer	2.54e-05	0.000606	CbGpPWpGaD
Methotrexate—ABCC4—Ectoderm Differentiation—MYC—germ cell cancer	2.48e-05	0.000591	CbGpPWpGaD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	2.46e-05	0.000586	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—AVP—germ cell cancer	2.46e-05	0.000585	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—CRABP1—germ cell cancer	2.38e-05	0.000566	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—SLC2A3—germ cell cancer	2.37e-05	0.000564	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—SLC22A3—germ cell cancer	2.33e-05	0.000556	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—AVP—germ cell cancer	2.33e-05	0.000555	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—FGFR3—germ cell cancer	2.31e-05	0.00055	CbGpPWpGaD
Methotrexate—MTHFR—Disease—FGF4—germ cell cancer	2.28e-05	0.000544	CbGpPWpGaD
Methotrexate—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	2.25e-05	0.000537	CbGpPWpGaD
Methotrexate—AOX1—Disease—FGF4—germ cell cancer	2.23e-05	0.000531	CbGpPWpGaD
Methotrexate—ABCB1—brain—germ cell cancer	2.18e-05	0.000344	CbGeAlD
Methotrexate—ALB—Hemostasis—CD9—germ cell cancer	2.18e-05	0.000518	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—CRABP1—germ cell cancer	2.16e-05	0.000515	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—SLC2A3—germ cell cancer	2.14e-05	0.000509	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—KIT—germ cell cancer	2.12e-05	0.000505	CbGpPWpGaD
Methotrexate—PGD—Disease—FGFR3—germ cell cancer	2.11e-05	0.000503	CbGpPWpGaD
Methotrexate—ABCB1—lymph node—germ cell cancer	2.11e-05	0.000333	CbGeAlD
Methotrexate—ABCC3—Metabolism—SLC22A3—germ cell cancer	2.11e-05	0.000501	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—AVP—germ cell cancer	2.11e-05	0.000501	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—CRABP1—germ cell cancer	2.07e-05	0.000494	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—AVP—germ cell cancer	2.06e-05	0.000491	CbGpPWpGaD
Methotrexate—MTHFR—Disease—H2AFZ—germ cell cancer	2.04e-05	0.000486	CbGpPWpGaD
Methotrexate—DHFR—Disease—FGF4—germ cell cancer	2.03e-05	0.000483	CbGpPWpGaD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	2.02e-05	0.000481	CbGpPWpGaD
Methotrexate—ABCC1—Disease—SLC2A3—germ cell cancer	2e-05	0.000476	CbGpPWpGaD
Methotrexate—AOX1—Disease—H2AFZ—germ cell cancer	1.99e-05	0.000474	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—AVP—germ cell cancer	1.98e-05	0.000471	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	1.94e-05	0.000462	CbGpPWpGaD
Methotrexate—PGD—Disease—KIT—germ cell cancer	1.94e-05	0.000462	CbGpPWpGaD
Methotrexate—TYMS—Circadian rythm related genes—TP53—germ cell cancer	1.94e-05	0.000462	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	1.91e-05	0.000455	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—CRABP1—germ cell cancer	1.9e-05	0.000453	CbGpPWpGaD
Methotrexate—MTHFR—Disease—KITLG—germ cell cancer	1.88e-05	0.000447	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—SLC2A3—germ cell cancer	1.86e-05	0.000443	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—SLC22A3—germ cell cancer	1.83e-05	0.000437	CbGpPWpGaD
Methotrexate—AOX1—Disease—KITLG—germ cell cancer	1.83e-05	0.000436	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—AVP—germ cell cancer	1.83e-05	0.000436	CbGpPWpGaD
Methotrexate—DHFR—Disease—H2AFZ—germ cell cancer	1.81e-05	0.000432	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—MYC—germ cell cancer	1.76e-05	0.00042	CbGpPWpGaD
Methotrexate—ALB—SLC-mediated transmembrane transport—AVP—germ cell cancer	1.76e-05	0.00042	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—AVP—germ cell cancer	1.72e-05	0.00041	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—CRABP1—germ cell cancer	1.72e-05	0.000409	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	1.7e-05	0.000405	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	1.68e-05	0.000399	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—SLC2A3—germ cell cancer	1.68e-05	0.000399	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—AVP—germ cell cancer	1.67e-05	0.000397	CbGpPWpGaD
Methotrexate—DHFR—Disease—KITLG—germ cell cancer	1.67e-05	0.000397	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—TP53—germ cell cancer	1.67e-05	0.000396	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—SLC22A3—germ cell cancer	1.65e-05	0.000393	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—AVP—germ cell cancer	1.65e-05	0.000393	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.64e-05	0.00039	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—SLC2A3—germ cell cancer	1.59e-05	0.000379	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—SLC22A3—germ cell cancer	1.57e-05	0.000373	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—AVP—germ cell cancer	1.57e-05	0.000373	CbGpPWpGaD
Methotrexate—FPGS—Disease—MYC—germ cell cancer	1.5e-05	0.000357	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—CRABP1—germ cell cancer	1.49e-05	0.000356	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—SLC2A3—germ cell cancer	1.47e-05	0.000351	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—SLC22A3—germ cell cancer	1.45e-05	0.000346	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—AVP—germ cell cancer	1.45e-05	0.000346	CbGpPWpGaD
Methotrexate—MTHFR—Disease—FGFR3—germ cell cancer	1.39e-05	0.000332	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—HRAS—germ cell cancer	1.38e-05	0.00033	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle, Mitotic—MYC—germ cell cancer	1.37e-05	0.000325	CbGpPWpGaD
Methotrexate—AOX1—Disease—FGFR3—germ cell cancer	1.36e-05	0.000324	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—CRABP1—germ cell cancer	1.35e-05	0.00032	CbGpPWpGaD
Methotrexate—MTHFR—Disease—KIT—germ cell cancer	1.28e-05	0.000305	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—CRABP1—germ cell cancer	1.28e-05	0.000304	CbGpPWpGaD
Methotrexate—AOX1—Disease—KIT—germ cell cancer	1.25e-05	0.000298	CbGpPWpGaD
Methotrexate—DHFR—Disease—FGFR3—germ cell cancer	1.24e-05	0.000295	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle—MYC—germ cell cancer	1.22e-05	0.000291	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle, Mitotic—MYC—germ cell cancer	1.19e-05	0.000284	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CRABP1—germ cell cancer	1.18e-05	0.000282	CbGpPWpGaD
Methotrexate—FPGS—Disease—HRAS—germ cell cancer	1.18e-05	0.00028	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—MYC—germ cell cancer	1.17e-05	0.000278	CbGpPWpGaD
Methotrexate—ABCC1—Disease—FGF4—germ cell cancer	1.15e-05	0.000274	CbGpPWpGaD
Methotrexate—DHFR—Disease—KIT—germ cell cancer	1.14e-05	0.000271	CbGpPWpGaD
Methotrexate—PGD—Disease—MYC—germ cell cancer	1.07e-05	0.000254	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle—MYC—germ cell cancer	1.07e-05	0.000254	CbGpPWpGaD
Methotrexate—ABCC1—Disease—H2AFZ—germ cell cancer	1.03e-05	0.000244	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle—TP53—germ cell cancer	1e-05	0.000239	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—TP53—germ cell cancer	9.67e-06	0.00023	CbGpPWpGaD
Methotrexate—ABCC1—Disease—KITLG—germ cell cancer	9.44e-06	0.000225	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—HRAS—germ cell cancer	9.25e-06	0.00022	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—HRAS—germ cell cancer	9.17e-06	0.000218	CbGpPWpGaD
Methotrexate—ALB—Metabolism—SLC2A3—germ cell cancer	9.1e-06	0.000217	CbGpPWpGaD
Methotrexate—ALB—Metabolism—SLC22A3—germ cell cancer	8.96e-06	0.000213	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—AVP—germ cell cancer	8.96e-06	0.000213	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle—TP53—germ cell cancer	8.75e-06	0.000208	CbGpPWpGaD
Methotrexate—PGD—Disease—HRAS—germ cell cancer	8.39e-06	0.0002	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—SLC2A3—germ cell cancer	7.97e-06	0.00019	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—SLC22A3—germ cell cancer	7.85e-06	0.000187	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	7.85e-06	0.000187	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	7.59e-06	0.000181	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CRABP1—germ cell cancer	7.3e-06	0.000174	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—TP53—germ cell cancer	7.21e-06	0.000172	CbGpPWpGaD
Methotrexate—MTHFR—Disease—MYC—germ cell cancer	7.05e-06	0.000168	CbGpPWpGaD
Methotrexate—ABCC1—Disease—FGFR3—germ cell cancer	7.02e-06	0.000167	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—HRAS—germ cell cancer	6.9e-06	0.000164	CbGpPWpGaD
Methotrexate—AOX1—Disease—MYC—germ cell cancer	6.88e-06	0.000164	CbGpPWpGaD
Methotrexate—ABCC1—Disease—KIT—germ cell cancer	6.44e-06	0.000153	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CRABP1—germ cell cancer	6.4e-06	0.000152	CbGpPWpGaD
Methotrexate—DHFR—Disease—MYC—germ cell cancer	6.26e-06	0.000149	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	6.24e-06	0.000148	CbGpPWpGaD
Methotrexate—MTHFR—Disease—HRAS—germ cell cancer	5.53e-06	0.000132	CbGpPWpGaD
Methotrexate—AOX1—Disease—HRAS—germ cell cancer	5.41e-06	0.000129	CbGpPWpGaD
Methotrexate—DHFR—Disease—HRAS—germ cell cancer	4.92e-06	0.000117	CbGpPWpGaD
Methotrexate—ABCC1—Disease—MYC—germ cell cancer	3.54e-06	8.44e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—TP53—germ cell cancer	3.26e-06	7.77e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—HRAS—germ cell cancer	3.12e-06	7.43e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—HRAS—germ cell cancer	2.78e-06	6.63e-05	CbGpPWpGaD
